Parkinson's Disease (30-75) - Long Beach CA (Clinical Trial # 40235)

You are viewing an inactive listing

This listing is not currently available. You can either be notified when it becomes available or browse nearby active listings below.

Click here to view additional nearby listings or search by keyword.

Clinical Trial 40235

Long Beach, CA 90806

Summary:

PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF DNL201 IN SUBJECTS WITH PARKINSON’S DISEASE

Qualified Participants Must:

• Subjects aged 30-75 years, with a clinical diagnosis of Parkinson's disease

Qualified Participants May Receive:

Compensation for time and travel

Research Site Profile

Nearby listings:

Click here to view additional nearby listings or search by keyword.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.

Services for Research Sites

National Recruitment Services

News And Information